COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 472: Articles 4711-4720  | Next

Probing Conformational Landscapes of Binding and Allostery in the SARS-CoV-2 Omicron Variant Complexes Using Microsecond Atomistic Simulations and Perturbation-Based Profiling Approaches: Hidden Role of Omicron Mutations as Modulators of Allosteric Signaling and Epistatic Relationships
Verkhivker, G., Alshahrani, M., Gupta, G., Xiao, S., Tao, P.
10.1101/2023.05.03.539337 — Posted: 2023-05-04
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
Ying, B., Darling, T. L., Desai, P., Liang, C.-Y., Dmitriev, I. P., Soudani, N., Bricker, T. L., Kashentseva, E. A., Harastani, H. H., Schmidt, A. G., Curiel, D. T., Boon, A. C. M., Diamond, M. S.
10.1101/2023.05.04.539332 — Posted: 2023-05-04
Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1
Choudhary, A. K., Calianese, D., Honnen, W., Kolloli, A., Dikdan, R. J., Jaijyan, D., Song, G., Capozzola, T., Akkaraju, V., Mattappallil, A., Rosania, A., Khan, S., Lerman, M., Afzal, N., Subbian, S., Chou, T. C., Andrabi, R., Burton, D., Pinter, A.
10.1101/2023.05.04.539267 — Posted: 2023-05-04
Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic
Colson, P., Chaudet, H., Delerce, J., Pontarotti, P., Levasseur, A., Fantini, J., La Scola, B., Devaux, C. A., Raoult, D.
10.1101/2023.05.01.538506 — Posted: 2023-05-04
A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19
Coronel Monje, K., Candia Puma, M. A., Vilca Alosilla, J. J., Goyzueta Mamani, L. D., Aguilar Bravo, H. M., Sanchez Zegarra, J. A., Barazorda Ccahuana, H. L., Ferraz Coelho, E. A., Chavez Fumagalli, M. A.
10.1101/2023.05.03.23289455 — Posted: 2023-05-03
Host-Microbiome Associations in Saliva Predict COVID-19 Severity
Alqaderi, H., Altabtbaei, K., Espinoza, J. L., Bin-Hasan, S., Alghounaim, M., Alawady, A., Altabtabae, A., AlJamaan, S., Devarajan, S., AlShammari, T., Eid, M. B., Matsuoka, M., Jang, H., Dupont, C., Freire, M.
10.1101/2023.05.02.539155 — Posted: 2023-05-03
Chronic alcohol consumption dysregulates innate immune response to SARS-CoV-2 in the lung
Lewis, S. A., Cinco, I. R., Doratt, B. M., Blanton, M. B., Hoagland, C., Davies, M., Grant, K. A., Messaoudi, I.
10.1101/2023.05.02.539139 — Posted: 2023-05-03
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV
Durstenfeld, M. S., Peluso, M. J., Spinelli, M. A., Li, D., Hoh, R., Gandhi, M., Henrich, T. J., Aras, M. A., Long, C. S., Deeks, S. G., Hsue, P. Y.
10.1101/2023.05.01.23289358 — Posted: 2023-05-02
Did knowledge, attitudes, and practices matter during the second wave of COVID-19 pandemic in Bangladesh? Results from a web-based cross-sectional study
Khan, M. R., Hossain, M. J., Islam, M. A., Zaman, S. U., Islam, M. T., Haque, M. A., Islam, M. R., Ripa, F. A., Islam, M. M., Ahmmed, F.
10.1101/2023.05.02.23289398 — Posted: 2023-05-02
COVID AMP: An Open Access Database of COVID-19 Response Policies
Katz, R., Toole, K., Robertson, H., Case, A., Kerr, J., Robinson-Marshall, S., Schermerhorn, J., Orsborn, S., Van Maele, M., Zimmerman, R., Stevens, T., COVID AMP Coding Team, , Phelan, A., Carlson, C. J., Graeden, E.
10.1101/2023.05.01.23289163 — Posted: 2023-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).